Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Chemosphere ; 308(Pt 2): 136408, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36103922

ABSTRACT

Ciprofloxacin antibiotic (CIP) is one of the antibiotics with the highest rate of antibiotic resistance, if used and managed improperly, can have a negative impact on the ecosystem. In this research, ZnO modified g-C3N4 photocatalyst was prepared and applied for the decomposition of CIP antibiotic compounds in water. The removal performance of CIP by using ZnO/g-C3N4 reached 93.8% under pH 8.0 and an increasing amount of catalyst could improve the degradation performance of the pollutant. The modified ZnO/g-C3N4 completely oxidized CIP at a low concentration of 1 mg L-1 and the CIP removal efficiency slightly decreases (around 13%) at a high level of pollutant (20 mg L-1). The degradation rate of CIP by doped sample ZnO/g-C3N4 was 4.9 times faster than that of undoped g-C3N4. The doped catalyst ZnO/g-C3N4 also displayed high reusability for decomposition of CIP with 89.8% efficiency remaining after 3 cycles. The radical species including ·OH, ·O2- and h+ are important in the CIP degradation process. In addition, the proposed mechanism for CIP degradation by visible light-assisted ZnO/g-C3N4 was claimed.


Subject(s)
Environmental Pollutants , Zinc Oxide , Anti-Bacterial Agents/chemistry , Catalysis , Ciprofloxacin/chemistry , Ecosystem , Light , Photolysis , Water
2.
Braz. J. Pharm. Sci. (Online) ; 58: e18837, 2022. tab, graf
Article in English | LILACS | ID: biblio-1374558

ABSTRACT

Abstract Recently, the acetate wheat starch (AWS) has been prepared by acetylation with an acetyl content of 2.42%, containing of rapidly digestible starch (RDS), slowly digestible starch (SDS) and resistant starch (RS) with 25.0%; 22.9% and 34.5%, respectively. In this study, this kind of starch was continuously evaluated with the postprandial blood glucose response and determined short-chain fatty acids (SCFAs) metabolized from AWS in the gastrointestinal tract of healthy mice by HPLC. The result showed that the mice fed with AWS exhibited a very limited increase in blood glucose level and remained stable for 2 hours after meals efficiently comparing with the control group fed with natural wheat starch (NWS). Simultaneously, the content of SCFAs produced in the caecum of the mice fed with AWS was significantly higher than mice fed with NWS, especially with acetic and propionic acids by 28% and 26%, respectively. Thus, AWS has shown to limit the postprandial hyperglycemia in mice effectively through the resistance to amylase hydrolysis in the small intestine. When going into the caecum, it is fermented to form SCFAs providing a part of energy for the body's activities, avoiding rotten fermentation causing digestive disorders which are inherent restrictions of normal high cellulose and fiber food.


Subject(s)
Animals , Male , Female , Mice , Starch/adverse effects , Triticum/classification , Hyperglycemia/pathology , Acetates/agonists , Chromatography, High Pressure Liquid/methods , Gastrointestinal Tract/abnormalities , Food/classification , Glucose/pharmacology
3.
Braz. J. Pharm. Sci. (Online) ; 58: e20890, 2022. tab, graf
Article in English | LILACS | ID: biblio-1420478

ABSTRACT

Abstract Resistant starch is particularly concerned with beneficial effects in regulating blood glucose concentration and lipid metabolism, reducing the risk of diabetes and cardiovascular diseases. This study aimed to validate the effects of wheat starch acetate containing 32.1% resistant starch on postprandial blood glucose response and lipid profile on obesity, dyslipidemia Swiss mice induced by a high-fat diet. The result showed that there was a restriction on postprandial hyperglycemia and remained stable for 2 hours after meal efficiently comparing with the control group fed natural wheat starch. Simultaneously, when maintaining the dose of 5g/kg once or twice a day for 8 weeks, wheat starch acetate to be able to reduce body weight and blood glucose, triglyceride, cholesterol levels compared to the control group (p<0.05)


Subject(s)
Animals , Male , Mice , Dyslipidemias/pathology , Resistant Starch/analysis , Acetates , Obesity/pathology , Starch/agonists , Cholesterol/adverse effects , Glucose/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...